News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare Conference
  

BOULDER, Colo., Sept.  3, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Morgan Stanley 2014 Global Healthcare Conference in New York City.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:

Morgan Stanley 2014 Global Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer

Date:

Wednesday, September 10, 2014

Time:

12:55 p.m. Eastern Time

Location:

Grand Hyatt New York

Webcast:

www.arraybiopharma.com

About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

SOURCE Array BioPharma